№ files_lp_3_process_9_33461
File format: docx
Character count: 25120
File size: 889 KB
This document provides detailed guidelines for the pathological examination and staging of gallbladder carcinoma specimens, including specimen types, data elements, and synoptic reporting requirements for accreditation.
Year:
2017
Region / City:
Not specified
Subject:
Gallbladder carcinoma examination protocol
Document Type:
Medical protocol
Organization / Institution:
Not specified
Author:
Sanjay Kakar, MD; Chanjuan Shi, MD, PhD; N. Volkan Adsay, MD; Patrick L. Fitzgibbons, MD; Wendy L. Frankel, MD; Alyssa M. Krasinskas, MD; Timothy Pawlik, MD, PhD; Jean-Nicolas Vauthey, MD; Mary K. Washington, MD, PhD
Target Audience:
Pathologists, oncologists, clinical laboratories
Validity Period:
Not specified
Approval Date:
Not specified
Revision Date:
March 2018
Accreditation Requirement:
Yes
Changes Summary:
Modified data elements for pTNM, tumor extension, histologic types, and margins
Additional Metadata:
Not applicable
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2017
Region / City:
Oxford, UK
Subject:
Oncology, TNM Classification
Document Type:
Appendix
Institution:
Wiley-Blackwell
Author:
Brierley JD, Gospodarowicz MK, Wittekind C
Target Audience:
Medical professionals, oncologists, pathologists
Period of validity:
1 January 2018 and onward
Date of Approval:
Not specified
Date of Revisions:
Not specified
Year:
Unknown
Region / City:
Unknown
Topic:
Gallbladder cancer mortality by demographic factors
Document type:
Table
Organization / Institution:
Unknown
Author:
Unknown
Target audience:
Medical professionals, researchers
Period of validity:
Unknown
Approval date:
Unknown
Date of changes:
Unknown
Year:
2024
Region / City:
Not specified
Subject:
Medical / Gastroenterology
Document type:
Research Article
Institution:
Not specified
Author:
Bang J, Arnoletti J, Wagner A, et al.
Target Audience:
Healthcare professionals, researchers
Duration:
Not applicable
Approval date:
Not specified
Modification date:
Not specified
Year:
2016–2019
Region / Location:
Multicenter clinical study
Disease Type:
Cholangiocarcinoma, Gallbladder carcinoma
Patient Count:
9
Patient Sex:
5 female, 4 male
Age Range:
51–80
Metastatic Sites:
Liver, lung, lymph nodes, peritoneum
Stage:
4
Treatment Type:
Investigational therapy in clinical trial
Start Dates:
5/9/2016 – 11/20/2019
End Dates:
6/9/2017 – 12/19/2019
Reason for Discontinuation:
Clinical decline, hospice, rapid progression, hospitalization, death, toxicity, gastrointestinal bleed
Follow-up Cut-off:
03/10/2021
Document Type:
Clinical trial appendix table
Source:
Study patient records
Version:
4.4.0.0
Protocol Posting Date:
June 2021
CAP Laboratory Accreditation Program Protocol Required Use Date:
March 2022
Authors:
Patrick L. Fitzgibbons, MD, FCAP; James L. Connolly, MD
Note:
Accreditation Requirements
Year:
2021
Region / City:
Global
Theme:
Oncology, Breast Cancer
Document Type:
Protocol
Organization / Institution:
CAP (College of American Pathologists)
Author:
Patrick L. Fitzgibbons, MD, FCAP; James L. Connolly, MD
Target Audience:
Medical professionals, pathologists
Period of Validity:
From March 2022
Date of Approval:
June 2021
Date of Changes:
June 2021
Year:
2024
Region / City:
Not specified
Subject:
Pathology, Oncology
Document Type:
Protocol
Organization / Institution:
CAP (College of American Pathologists)
Author:
Uma G. Krishnamurti, MD, PhD; Kimberly H. Allison, MD; Patrick L. Fitzgibbons, MD, FCAP; James L. Connolly, MD
Target Audience:
Pathologists, Medical Institutions
Period of Validity:
March 2025
Approval Date:
Not specified
Date of Last Change:
June 2024
Version:
4.2.0.1
Protocol Posting Date:
June 2022
CAP Laboratory Accreditation Program Protocol Required Use Date:
March 2022
For accreditation purposes:
Surgical resection, including esophagectomy and esophagogastrectomy; Epithelial tumors of the esophagus, and esophagogastric junction with tumor involvement of no more than 2 cm into the proximal stomach.
Authors:
Lawrence J. Burgart, MD; William V. Chopp, MD; Dhanpat Jain, MD
Synoptic Reporting:
Core and conditional data elements must be reported in a synoptic format for accreditation.
Case Summary:
Esophagus
Histologic Type:
Adenocarcinoma, Squamous cell carcinoma, Neuroendocrine carcinoma, among others.
Version:
1.2.0.0
Protocol posting date:
March 2023
Document type:
Clinical pathology protocol
Medical field:
Breast pathology, oncology
Procedures covered:
Needle biopsy, fine needle aspiration, other biopsy procedures
Tumor types included:
Invasive breast carcinoma of any type, with or without ductal carcinoma in situ
Tumor types excluded:
Ductal carcinoma in situ without invasion, Paget disease without invasion, phyllodes tumor, lymphoma, sarcoma
Authors:
Patrick L. Fitzgibbons, MD, FCAP; James L. Connolly, MD
Organization:
College of American Pathologists
Accreditation status:
Recommended for clinical care, not required for accreditation
Intended use:
Reporting of biopsy specimens
Updates:
Optional reporting of largest invasive focus; revised lymphatic and/or vascular invasion terminology
Version:
4.2.1.0
Protocol Posting Date:
June 2025
CAP Laboratory Accreditation Program Protocol Required Use Date:
March 2026
Year:
2025
Region / City:
Not specified
Subject:
Renal cell carcinoma, nephrectomy, tumor classification
Document Type:
Protocol
Institution:
CAP (College of American Pathologists)
Author:
Paari Murugan, MD, FCAP*, Robert W. Allan, MD, FCAP*, Lara R. Harik, MD, FCAP*
Target Audience:
Pathologists, medical professionals involved in cancer diagnostics
Effective Period:
March 2026 onward
Approval Date:
June 2025
Revision Date:
Not specified
Year:
2021
Region / city:
University of Washington Medical Center
Topic:
Diagnostic Ultrasound Protocol
Document Type:
Protocol
Organization:
University of Washington Medical Center
Author:
Unknown
Target Audience:
Medical Professionals
Period of validity:
Not specified
Approval Date:
10/25/2021
Date of changes:
10/25/2021
Context:
A medical protocol detailing diagnostic ultrasound procedures for screening of liver conditions including Hepatocellular Carcinoma (HCC) and Right Upper Quadrant (RUQ) evaluation at the University of Washington Medical Center.
Year:
2014
Region / city:
India
Type of document:
Original research article
Field:
Oral and maxillofacial pathology
Authors:
R Syedmukith, BR Ahmedmujib, TS Bastian
Study period:
1997–2005
Sample size:
75 patients
Age groups:
≤40 years and >40 years
Follow-up duration:
5 years
Staging system:
STNMP (site, tumor, node, metastasis, pathology)
Conflict of interest:
None
Funding:
Nil
Year:
2023
Region / City:
N/A
Topic:
Lung Cancer Treatment, Immunotherapy
Document Type:
Research Paper
Author:
Ayush Chalishajar
Target Audience:
Researchers, Medical Professionals, Academics
Period of Action:
January 15th - March 19th
Approval Date:
N/A
Date of Changes:
N/A
Year:
2022
Region / city:
Nanjing
Topic:
Hepatocellular Carcinoma, Gut Microbiota, Immunology
Document type:
Supplementary Materials
Organization / institution:
Nanjing Medical University
Author:
Chupeng Hu, Bingqing Xu, Yun Chen
Target audience:
Researchers, scientists, medical professionals
Period of validity:
Not specified
Approval date:
Not specified
Date of changes:
Not specified
Year:
2023
Region / city:
Not specified
Subject:
Oncology, Pathology
Document type:
Protocol
Organization / institution:
CAP (College of American Pathologists)
Author:
Barbara A. Crothers, Uma G. Krishnamurti, Veronica Klepeis, Gulisa Turashvili, Oluwole Fadare, Stephanie Skala
Target audience:
Pathologists, Oncology professionals
Period of validity:
September 2024
Approval date:
December 2023
Modification date:
Not specified
Year:
2010-2024
Region / city:
Asia-Pacific
Subject:
Hepatology
Document Type:
Clinical Practice Guidelines
Organization / Institution:
Asian Pacific Association for the Study of the Liver (APASL)
Author:
APASL
Target Audience:
Healthcare professionals
Period of validity:
2010-2024
Date of approval:
2010
Date of revisions:
2024
Context:
Collection of clinical practice guidelines and consensus statements issued by the Asian Pacific Association for the Study of the Liver on various hepatological conditions, including hepatocellular carcinoma, hepatitis B and C, liver transplantation, and metabolic diseases.
Version:
4.4.2.0
Protocol Posting Date:
March 2023
Document Type:
Clinical reporting protocol and case summary template
Subject:
Primary carcinoma of the uterine cervix
Applicable Procedures:
Excision (cold knife cone, LEEP, LLETZ)
Applicable Tumor Types:
Carcinoma; Carcinosarcoma
Excluded Procedures:
Resection; Cytologic specimens
Excluded Tumor Types:
Lymphoma; Sarcoma
Authors:
Barbara A. Crothers, DO; Uma G. Krishnamurti, MD, PhD; George G. Birdsong, MD; Veronica Klepeis, MD, PhD; Saeid Movahedi-Lankarani, MD; Christopher N. Otis, MD
Issuing Organization:
College of American Pathologists (CAP)
Committees:
CAP Cancer Committee; CAP Pathology Electronic Reporting Committee
Accreditation Status:
Recommended for clinical care; not required for accreditation
Staging Reference:
AJCC Staging Manual
Scope:
Pathologic evaluation and reporting of excision specimens from the uterine cervix
Year:
Not specified
Region / City:
Not specified
Topic:
Cancer research, Urothelial carcinoma
Document type:
Research methodology
Institution:
Not specified
Author:
Not specified
Target audience:
Researchers in oncology and immunology
Period of validity:
Not specified
Approval date:
Not specified
Modification date:
Not specified
Year:
2021
Region / City:
Global
Topic:
Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer, Histopathology
Document Type:
Reporting Guide
Organization / Institution:
International Collaboration on Cancer Reporting (ICCR)
Author:
Merlin T, Weston A, Tooher R
Target Audience:
Pathologists, Oncologists, Medical Researchers
Effective Period:
2021 onwards
Approval Date:
2021
Date of Changes:
June 2021
Year:
2021
Region / city:
Amsterdam, The Netherlands
Topic:
Oropharyngeal carcinoma, radiation therapy
Document type:
Research article
Institution:
Netherlands Cancer Institute, UMC Utrecht Cancer Center
Author:
Rebecca T. Karsten, Najiba Chargi, Lisette van der Molen, Rob J.J.H. van Son, Remco de Bree, Abrahim Al-Mamgani, Jan P. de Boer, Frans J.M. Hilgers, Michiel W.M. van den Brekel, Ludi E. Smeele, Martijn M. Stuiver
Target audience:
Researchers, medical professionals in oncology and rehabilitation
Period of validity:
N/A
Approval date:
N/A
Date of changes:
N/A
Version:
1.5.0.0
Protocol Posting Date:
June 2024
CAP Laboratory Accreditation Program Protocol Required Use Date:
March 2025
Authors:
Gulisa Turashvili, MD, PhD; Uma G. Krishnamurti, MD, PhD; Barbara A. Crothers, DO; Giovanna A. Giannico, MD; Krisztina Hanley, MD; Anna Plotkin, MD; Anthony N. Karnezis, MD, PhD.
Note:
Accreditation Requirements
Date of Protocol Posting:
June 2024
Date of Required Use:
March 2025